We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRVB
2851
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$85K ﹤0.01%
+10,063
New +$81.2K
TMBR
2852
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$84K ﹤0.01%
+1,380
New +$97K
QUMU
2853
DELISTED
Qumu Corp.
QUMU
$83K ﹤0.01%
28,750
+1,100
+4% +$5.41K
HIL
2854
DELISTED
Hill International, Inc. Common Stock
HIL
$83K ﹤0.01%
33,200
+15,600
+89% +$41.6K
FPAY
2855
DELISTED
FlexShopper
FPAY
$82K ﹤0.01%
27,700
+14,400
+108% +$38.2K
CTIC
2856
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$82K ﹤0.01%
32,700
DWSN icon
2857
Dawson Geophysical
DWSN
$136M
$81K ﹤0.01%
30,980
EXTN
2858
DELISTED
Exterran Corporation
EXTN
$81K ﹤0.01%
17,000
-1,746
-9% -$7.48K
DHT icon
2859
DHT Holdings
DHT
$3.01B
$78K ﹤0.01%
+11,977
New +$73.5K
MMAT
2860
DELISTED
Meta Materials Inc. Common Stock
MMAT
$78K ﹤0.01%
+104
New +$58K
ADXS
2861
DELISTED
Advaxis Inc
ADXS
$77K ﹤0.01%
166,748
VRAY
2862
DELISTED
ViewRay, Inc.
VRAY
$76K ﹤0.01%
+11,570
New +$61.7K
UUUU icon
2863
Energy Fuels
UUUU
$3.62B
$72K ﹤0.01%
+11,850
New +$72.7K
ACGN
2864
DELISTED
Aceragen Inc
ACGN
$72K ﹤0.01%
3,556
+2,596
+270% +$52.3K
IGC icon
2865
IGC Pharma
IGC
$29.8M
$71K ﹤0.01%
43,000
SONN
2866
DELISTED
Sonnet BioTherapeutics
SONN
$71K ﹤0.01%
18
HLX icon
2867
Helix Energy Solutions
HLX
$1.49B
$69K ﹤0.01%
+12,018
New +$63.2K
QUAD icon
2868
Quad
QUAD
$507M
$69K ﹤0.01%
16,700
-2,138
-11% -$7.75K
MACK
2869
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$67K ﹤0.01%
10,500
CTXR icon
2870
Citius Pharmaceuticals
CTXR
$21M
$66K ﹤0.01%
760
+344
+83% +$20.7K
BOAC.WS
2871
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$66K ﹤0.01%
49,000
KRMD icon
2872
KORU Medical Systems
KRMD
$152M
$65K ﹤0.01%
14,100
-1,926
-12% -$7.56K
EMAN
2873
DELISTED
eMagin Corporation
EMAN
$64K ﹤0.01%
18,500
APRN
2874
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$63K ﹤0.01%
1,225
-758
-38% -$48.2K
HAACW
2875
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$63K ﹤0.01%
35,000

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.